Susie Wyss used to inject herself daily with a medication for multiple sclerosis. “The injection hurt. It caused welts, ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis in women, according to study findings.

A recent study shows that menopause may worsen Multiple Sclerosis symptoms and accelerate its progression due to a decline in ...

A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...

The rate of frailty among patients with multiple sclerosis (MS) ranges from 17% to 66% among ambulatory patients, and frailty among MS patients is linked to a host of complications. Read about the ...

While there’s no cure for multiple sclerosis (MS), there are many treatments available. These treatments mainly focus on slowing down the progression of the disease and managing symptoms.

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

The FDA is adding a new boxed warning to include information that anaphylaxis can occur at any time, from as early as after ...

After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 births ...

Cohen, an Emmy Award-winning journalist who built his career as a producer at both CBS News and CNN, had lived for more than 50 years prior to his death with multiple sclerosis, an autoimmune ...